{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:33:43Z","timestamp":1776404023351,"version":"3.51.2"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["00451A121"],"award-info":[{"award-number":["00451A121"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s11894-023-00906-4","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T02:01:47Z","timestamp":1701914507000},"page":"9-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Dhiren","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folashade","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baha","family":"Moshiree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"issue":"2","key":"906_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcf.2022.10.006","volume":"22","author":"B Moshiree","year":"2023","unstructured":"Moshiree B, Freeman AJ, Vu PT, Khan U, Ufret-Vincenty C, Heltshe SL, et al. Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis. J Cyst Fibros. 2023;22(2):266\u201374.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"906_CR2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1378\/chest.118.4.1214","volume":"118","author":"SM Palmer","year":"2000","unstructured":"Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest. 2000;118(4):1214\u20137.","journal-title":"Chest"},{"issue":"5","key":"906_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jcf.2010.06.004","volume":"9","author":"AA Sabati","year":"2010","unstructured":"Sabati AA, Kempainen RR, Milla CE, Ireland M, Schwarzenberg SJ, Dunitz JM, et al. Characteristics of gastroesophageal reflux in adults with cystic fibrosis. J Cyst Fibros. 2010;9(5):365\u201370.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"906_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","volume":"22","author":"SJ Schwarzenberg","year":"2023","unstructured":"Schwarzenberg SJ, Vu PT, Skalland M, Hoffman LR, Pope C, Gelfond D, et al. Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: report of promise-GI. J Cyst Fibros. 2023;22(2):282\u20139.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"906_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40271-019-00361-2","volume":"12","author":"A Jaudszus","year":"2019","unstructured":"Jaudszus A, Zeman E, Jans T, Pfeifer E, Tabori H, Arnold C, et al. Validity and reliability of a novel multimodal questionnaire for the assessment of abdominal symptoms in people with cystic fibrosis (CFAbd-Score). Patient. 2019;12(4):419\u201328.","journal-title":"Patient"},{"issue":"3","key":"906_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10620-013-2950-0","volume":"59","author":"FW Woodley","year":"2014","unstructured":"Woodley FW, Machado RS, Hayes D Jr, Di Lorenzo C, Kaul A, Skaggs B, et al. Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis. Dig Dis Sci. 2014;59(3):623\u201330.","journal-title":"Dig Dis Sci"},{"issue":"41","key":"906_CR7","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.3748\/wjg.v26.i41.6322","volume":"26","author":"A Bongiovanni","year":"2020","unstructured":"Bongiovanni A, Manti S, Parisi GF, Papale M, Mule E, Rotolo N, et al. Focus on gastroesophageal reflux disease in patients with cystic fibrosis. World J Gastroenterol. 2020;26(41):6322\u201334.","journal-title":"World J Gastroenterol"},{"key":"906_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.21037\/tgh.2019.08.11","volume":"4","author":"FW Woodley","year":"2019","unstructured":"Woodley FW, Hayes D Jr, Kopp BT, Moore-Clingenpeel M, Machado RS, Nemastil CJ, et al. Gastroesophageal reflux in cystic fibrosis across the age spectrum. Transl Gastroenterol Hepatol. 2019;4:69.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"3","key":"906_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","volume":"19","author":"SG Kapnadak","year":"2020","unstructured":"Kapnadak SG, Dimango E, Hadjiliadis D, Hempstead SE, Tallarico E, Pilewski JM, et al. Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease. J Cyst Fibros. 2020;19(3):344\u201354.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"906_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","volume":"66","author":"R Rosen","year":"2018","unstructured":"Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"906_CR11","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.healun.2004.11.312","volume":"24","author":"BM Button","year":"2005","unstructured":"Button BM, Roberts S, Kotsimbos TC, Levvey BJ, Williams TJ, Bailey M, et al. Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J Heart Lung Transplant. 2005;24(10):1522\u20139.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"906_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1572-0241.2005.41217.x","volume":"100","author":"KR DeVault","year":"2005","unstructured":"DeVault KR, Castell DO, American College of G. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100(1):190\u2013200.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"906_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jamcollsurg.2013.05.023","volume":"217","author":"BA Jobe","year":"2013","unstructured":"Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, et al. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg. 2013;217(4):586\u201397.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"906_CR14","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","volume":"20","author":"R Yadlapati","year":"2022","unstructured":"Yadlapati R, Gyawali CP, Pandolfino JE, Participants CGCC. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol. 2022;20(5):984-94 e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"906_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ppul.22630","volume":"48","author":"SI Sheikh","year":"2013","unstructured":"Sheikh SI, Ryan-Wenger NA, McCoy KS. Outcomes of surgical management of severe GERD in patients with cystic fibrosis. Pediatr Pulmonol. 2013;48(6):556\u201362.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"906_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jcf.2021.07.002","volume":"20","author":"M Sathe","year":"2021","unstructured":"Sathe M, Moshiree B, Vu PT, Khan U, Heltshe SL, Romasco M, et al. Utilization of electronic patient-reported outcome measures in cystic fibrosis research: Application to the GALAXY study. J Cyst Fibros. 2021;20(4):605\u201311.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"906_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ppul.26257","volume":"58","author":"M Sathe","year":"2023","unstructured":"Sathe M, Moshiree B, Aliaj E, Lee M, Hudson J, Gifford A, et al. Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators. Pediatr Pulmonol. 2023;58(3):811\u20138.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"906_CR18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s10620-009-0725-4","volume":"54","author":"V Mertens","year":"2009","unstructured":"Mertens V, Blondeau K, Pauwels A, Farre R, Vanaudenaerde B, Vos R, et al. Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients. Dig Dis Sci. 2009;54(5):972\u20139.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"906_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10620-009-1038-3","volume":"55","author":"B Moshiree","year":"2010","unstructured":"Moshiree B, McDonald R, Hou W, Toskes PP. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci. 2010;55(3):675\u201383.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"906_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/00365521.2012.654402","volume":"47","author":"P Chini","year":"2012","unstructured":"Chini P, Toskes PP, Waseem S, Hou W, McDonald R, Moshiree B. Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. Scand J Gastroenterol. 2012;47(4):422\u20137.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"906_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1053\/j.gastro.2008.12.047","volume":"136","author":"HK Jung","year":"2009","unstructured":"Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136(4):1225\u201333.","journal-title":"Gastroenterology"},{"key":"906_CR22","first-page":"2918139","volume":"2016","author":"JE Corral","year":"2016","unstructured":"Corral JE, Dye CW, Mascarenhas MR, Barkin JS, Salathe M, Moshiree B. Is gastroparesis found more frequently in patients with cystic fibrosis? A systematic review. Scientifica (Cairo). 2016;2016:2918139.","journal-title":"Scientifica (Cairo)"},{"issue":"1","key":"906_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.giec.2018.08.010","volume":"29","author":"B Moshiree","year":"2019","unstructured":"Moshiree B, Potter M, Talley NJ. Epidemiology and Pathophysiology of Gastroparesis. Gastrointest Endosc Clin N Am. 2019;29(1):1\u201314.","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"9","key":"906_CR24","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s10620-009-1076-x","volume":"55","author":"M Sanaka","year":"2010","unstructured":"Sanaka M, Yamamoto T, Kuyama Y. Effects of proton pump inhibitors on gastric emptying: a systematic review. Dig Dis Sci. 2010;55(9):2431\u201340.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"906_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1053\/j.gastro.2011.01.046","volume":"140","author":"M Grover","year":"2011","unstructured":"Grover M, Farrugia G, Lurken MS, Bernard CE, Faussone-Pellegrini MS, Smyrk TC, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140(5):1575-85 e8.","journal-title":"Gastroenterology"},{"issue":"2","key":"906_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF01308170","volume":"37","author":"MS Murphy","year":"1992","unstructured":"Murphy MS, Brunetto AL, Pearson AD, Ghatei MA, Nelson R, Eastham EJ, et al. Gut hormones and gastrointestinal motility in children with cystic fibrosis. Dig Dis Sci. 1992;37(2):187\u201392.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"906_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2982.2007.01061.x","volume":"20","author":"D Cassilly","year":"2008","unstructured":"Cassilly D, Kantor S, Knight LC, Maurer AH, Fisher RS, Semler J, et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil. 2008;20(4):311\u20139.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"906_CR28","first-page":"527","volume":"22","author":"L Kloetzer","year":"2010","unstructured":"Kloetzer L, Chey WD, McCallum RW, Koch KL, Wo JM, Sitrin M, et al. Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterol Motil. 2010;22(5):527\u201333, e117.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"906_CR29","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2004.09.055","volume":"127","author":"HP Parkman","year":"2004","unstructured":"Parkman HP, Hasler WL, Fisher RS, American GA. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127(5):1592\u2013622.","journal-title":"Gastroenterology"},{"issue":"12","key":"906_CR30","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.14309\/ajg.0000000000001532","volume":"116","author":"DA Carlson","year":"2021","unstructured":"Carlson DA, Gyawali CP, Khan A, Yadlapati R, Chen J, Chokshi RV, et al. Classifying esophageal motility by FLIP panometry: a study of 722 subjects with manometry. Am J Gastroenterol. 2021;116(12):2357\u201366.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"906_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jcf.2020.06.004","volume":"20","author":"C Ng","year":"2021","unstructured":"Ng C, Dellschaft NS, Hoad CL, Marciani L, Ban L, Prayle AP, et al. Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging. J Cyst Fibros. 2021;20(4):591\u20137.","journal-title":"J Cyst Fibros"},{"key":"906_CR32","unstructured":"FDA. Domperidone, FDA IND 2021 [Available from: https:\/\/www.fda.gov\/drugs\/investigational-new-drug-ind-application\/how-request-domperidone-expanded-access-use. Accessed 2021."},{"issue":"5","key":"906_CR33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/archsurg.1985.01390290090015","volume":"120","author":"HA Pitt","year":"1985","unstructured":"Pitt HA, Mann LL, Berquist WE, Ament ME, Fonkalsrud EW, DenBesten L. Chronic intestinal pseudo-obstruction. Management with total parenteral nutrition and a venting enterostomy. Arch Surg. 1985;120(5):614\u20138.","journal-title":"Arch Surg"},{"issue":"24","key":"906_CR34","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.3748\/wjg.v20.i24.7739","volume":"20","author":"AA Rahnemai-Azar","year":"2014","unstructured":"Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20(24):7739\u201351.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"906_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1056\/NEJM199607253350416","volume":"335","author":"DK Wysowski","year":"1996","unstructured":"Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med. 1996;335(4):290\u20131.","journal-title":"N Engl J Med"},{"issue":"2","key":"906_CR36","first-page":"120","volume":"21","author":"EM Tillman","year":"2016","unstructured":"Tillman EM, Smetana KS, Bantu L, Buckley MG. Pharmacologic treatment for pediatric gastroparesis: a review of the literature. J Pediatr Pharmacol Ther. 2016;21(2):120\u201332.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"6","key":"906_CR37","first-page":"976","volume":"92","author":"I Soykan","year":"1997","unstructured":"Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol. 1997;92(6):976\u201380.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"906_CR38","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s10620-018-4976-9","volume":"63","author":"Z Malik","year":"2018","unstructured":"Malik Z, Kataria R, Modayil R, Ehrlich AC, Schey R, Parkman HP, et al. Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience. Dig Dis Sci. 2018;63(9):2405\u201312.","journal-title":"Dig Dis Sci"},{"issue":"15","key":"906_CR39","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.3748\/wjg.v21.i15.4574","volume":"21","author":"RA Schatz","year":"2015","unstructured":"Schatz RA, Zhang Q, Lodhia N, Shuster J, Toskes PP, Moshiree B. Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients. World J Gastroenterol. 2015;21(15):4574\u201382.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"906_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112(5):775\u201384.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"906_CR41","doi-asserted-by":"publisher","first-page":"e0174463","DOI":"10.1371\/journal.pone.0174463","volume":"12","author":"H Tabori","year":"2017","unstructured":"Tabori H, Arnold C, Jaudszus A, Mentzel HJ, Renz DM, Reinsch S, et al. Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings. PLoS ONE. 2017;12(5):e0174463.","journal-title":"PLoS ONE"},{"issue":"3","key":"906_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00535-018-1509-4","volume":"54","author":"M Furnari","year":"2019","unstructured":"Furnari M, De Alessandri A, Cresta F, Haupt M, Bassi M, Calvi A, et al. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin. J Gastroenterol. 2019;54(3):261\u201370.","journal-title":"J Gastroenterol"},{"issue":"2","key":"906_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MPG.0b013e31802c0ceb","volume":"44","author":"JL Fridge","year":"2007","unstructured":"Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2007;44(2):212\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"906_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","volume":"115","author":"M Pimentel","year":"2020","unstructured":"Pimentel M, Saad RJ, Long MD, Rao SSC. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165\u201378.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"906_CR45","doi-asserted-by":"publisher","first-page":"e00078","DOI":"10.14309\/ctg.0000000000000078","volume":"10","author":"SSC Rao","year":"2019","unstructured":"Rao SSC, Bhagatwala J. Small intestinal bacterial overgrowth: clinical features and therapeutic management. Clin Transl Gastroenterol. 2019;10(10):e00078.","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"906_CR46","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/apt.12304","volume":"37","author":"C Jacobs","year":"2013","unstructured":"Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SS. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth. Aliment Pharmacol Ther. 2013;37(11):1103\u201311.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"906_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11894-021-00806-5","volume":"23","author":"SJ Burton","year":"2021","unstructured":"Burton SJ, Hachem C, Abraham JM. Luminal gastrointestinal manifestations of cystic fibrosis. Curr Gastroenterol Rep. 2021;23(3):4.","journal-title":"Curr Gastroenterol Rep"},{"key":"906_CR48","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.14309\/01.ajg.0000704076.84304.8a","volume":"115","author":"B Moshiree","year":"2020","unstructured":"Moshiree B, Khan A, Jones ML, Singh S, Wahl C, Chuang E. S0507\u2003SIBO diagnosis: clinical survey of practice patterns, unmet needs, and perception of a novel ingestible diagnostic capsule. Off J Am Coll Gastroenterol | ACG. 2020;115:S236\u20137.","journal-title":"Off J Am Coll Gastroenterol | ACG"},{"key":"906_CR49","doi-asserted-by":"publisher","first-page":"S644","DOI":"10.14309\/01.ajg.0000707176.78864.91","volume":"115","author":"SS Rao","year":"2020","unstructured":"Rao SS, Moshiree B, Lee N, Jones ML, Chuang E, Singh S. S1282\u2003Evaluation of Smart Capsule Bacterial Detection System (SCBDS) assay and duodenal culture in subjects suspected of SIBO and undergoing upper endoscopy: interim analysis. Off J Am Coll Gastroenterol | ACG. 2020;115:S644.","journal-title":"Off J Am Coll Gastroenterol | ACG"},{"issue":"3","key":"906_CR50","doi-asserted-by":"publisher","first-page":"G577","DOI":"10.1152\/ajpgi.00195.2007","volume":"293","author":"RC De Lisle","year":"2007","unstructured":"De Lisle RC, Roach E, Jansson K. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2007;293(3):G577\u201384.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"906_CR51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/apt.12479","volume":"38","author":"SC Shah","year":"2013","unstructured":"Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38(8):925\u201334.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"906_CR52","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2036.2004.01900.x","volume":"19","author":"AV Emmanuel","year":"2004","unstructured":"Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther. 2004;19(6):687\u201394.","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"906_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF01300701","volume":"31","author":"T Tomomasa","year":"1986","unstructured":"Tomomasa T, Kuroume T, Arai H, Wakabayashi K, Itoh Z. Erythromycin induces migrating motorcomplex in human gastrointestinal tract. Dig Dis Sci. 1986;31(2):157\u201361.","journal-title":"Dig Dis Sci."},{"issue":"9","key":"906_CR54","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/j.1572-0241.2007.01255.x","volume":"102","author":"SC Reddymasu","year":"2007","unstructured":"Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007;102(9):2036\u201345.","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"906_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11894-020-0748-8","volume":"22","author":"Z Gonzalez","year":"2020","unstructured":"Gonzalez Z, McCallum R. Small bowel dysmotility, pseudoobstruction, and functional correlation with histopathology: lessons learned. Curr Gastroenterol Rep. 2020;22(3):14.","journal-title":"Curr Gastroenterol Rep."},{"key":"906_CR56","doi-asserted-by":"crossref","unstructured":"Lipton AB, Knauer CM. Pseudo-obstruction of the bowel. Therapeutic trial of metoclopramide. Am J\u00a0Dig Dis. 1977;22(3):263-5","DOI":"10.1007\/BF01072287"},{"issue":"1","key":"906_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-2036.2011.04907.x","volume":"35","author":"AV Emmanuel","year":"2012","unstructured":"Emmanuel AV, Kamm MA, Roy AJ, Kerstens R, Vandeplassche L. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction\u2013a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther. 2012;35(1):48\u201355.","journal-title":"Aliment Pharmacol Ther."},{"issue":"21","key":"906_CR58","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1056\/NEJM199111213252102","volume":"325","author":"HC Soudah","year":"1991","unstructured":"Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325(21):1461\u20137.","journal-title":"N Engl J Med."},{"issue":"9","key":"906_CR59","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1007\/BF02208652","volume":"40","author":"GN Verne","year":"1995","unstructured":"Verne GN, Eaker EY, Hardy E, Sninsky CA. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci. 1995;40(9):1892\u2013901.","journal-title":"Dig Dis Sci."},{"issue":"2","key":"906_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2036.1998.00289.x","volume":"12","author":"MC Edmunds","year":"1998","unstructured":"Edmunds MC, Chen JD, Soykan I, Lin Z, McCallum RW. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis. Aliment Pharmacol Ther. 1998;12(2):167\u201374.","journal-title":"Aliment Pharmacol Ther."},{"issue":"12","key":"906_CR61","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/nmo.12669","volume":"27","author":"G Parthasarathy","year":"2015","unstructured":"Parthasarathy G, Ravi K, Camilleri M, Andrews C, Szarka LA, Low PA, Zinsmeister AR, Bharucha AE. Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. Neurogastroenterol Motil. 2015;27(12):1736\u201346.","journal-title":"Neurogastroenterol Motil."},{"issue":"6","key":"906_CR62","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1463-1318.2009.01838.x","volume":"12","author":"CJ O'Dea","year":"2010","unstructured":"O\u2019Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010;12(6):540\u20138.","journal-title":"Colorectal Dis."},{"issue":"2","key":"906_CR63","first-page":"112","volume":"3","author":"AC Dukowicz","year":"2007","unstructured":"Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007;3(2):112\u201322.","journal-title":"Gastroenterol Hepatol (N Y)."},{"issue":"3","key":"906_CR64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1542\/peds.78.3.473","volume":"78","author":"S Rubinstein","year":"1986","unstructured":"Rubinstein S, Moss R, Lewiston N. Constipation and meconium ileus equivalent in patients with cystic fibrosis. Pediatrics. 1986;78(3):473\u20139.","journal-title":"Pediatrics"},{"issue":"6","key":"906_CR65","first-page":"CD012619","volume":"6","author":"J Green","year":"2018","unstructured":"Green J, Gilchrist FJ, Carroll W. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. Cochrane Database Syst Rev. 2018;6(6):CD012619.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"906_CR66","doi-asserted-by":"publisher","first-page":"a009480","DOI":"10.1101\/cshperspect.a009480","volume":"2","author":"C Ferec","year":"2012","unstructured":"Ferec C, Cutting GR. Assessing the disease-liability of mutations in CFTR. Cold Spring Harb Perspect Med. 2012;2(12):a009480.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"906_CR67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jcf.2022.12.011","volume":"22","author":"D Patel","year":"2023","unstructured":"Patel D, Mathews S, van Unen V, Chan JE, Al-Hammadi N, Borowitz D, et al. Impaired distal colonic pH in adults with cystic fibrosis. J Cyst Fibros. 2023;22(2):290\u20135.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"906_CR68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000003202","volume":"73","author":"MD de Sillos","year":"2021","unstructured":"de Sillos MD, Chiba SM, Soares ACF, Gomes CET, de Morais MB. Colonic transit time and fecal impaction in children and adolescents with cystic fibrosis-associated constipation. J Pediatr Gastroenterol Nutr. 2021;73(3):319\u201324.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8\u20139","key":"906_CR69","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365521.2012.699548","volume":"47","author":"C Hedsund","year":"2012","unstructured":"Hedsund C, Gregersen T, Joensson IM, Olesen HV, Krogh K. Gastrointestinal transit times and motility in patients with cystic fibrosis. Scand J Gastroenterol. 2012;47(8\u20139):920\u20136.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"906_CR70","first-page":"466","volume":"66","author":"J Hen Jr","year":"1980","unstructured":"Hen J Jr, Dolan TF Jr, Touloukian RJ. Meconium plug syndrome associated with cystic fibrosis and Hirschsprung\u2019s disease. Pediatrics. 1980;66(3):466\u20138.","journal-title":"Pediatrics"},{"issue":"9","key":"906_CR71","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00383-008-2199-4","volume":"24","author":"C Esposito","year":"2008","unstructured":"Esposito C, Sammarco G, De Fazio C, Alicchio F, Settimi A. Another case of cystic fibrosis complicated by meconium ileus associated with Hirschsprung\u2019s disease: a rare and important association. Pediatr Surg Int. 2008;24(9):1069\u201371.","journal-title":"Pediatr Surg Int"},{"issue":"4","key":"906_CR72","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0016-5085(82)90315-8","volume":"82","author":"RC Stern","year":"1982","unstructured":"Stern RC, Izant RJ Jr, Boat TF, Wood RE, Matthews LW, Doershuk CF. Treatment and prognosis of rectal prolapse in cystic fibrosis. Gastroenterology. 1982;82(4):707\u201310.","journal-title":"Gastroenterology"},{"issue":"9","key":"906_CR73","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM195808282590901","volume":"259","author":"LL Kulczycki","year":"1958","unstructured":"Kulczycki LL, Shwachman H. Studies in cystic fibrosis of the pancreas; occurrence of rectal prolapse. N Engl J Med. 1958;259(9):409\u201312.","journal-title":"N Engl J Med"},{"issue":"1","key":"906_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/MPG.0000000000000546","volume":"60","author":"KI El-Chammas","year":"2015","unstructured":"El-Chammas KI, Rumman N, Goh VL, Quintero D, Goday PS. Rectal prolapse and cystic fibrosis. J Pediatr Gastroenterol Nutr. 2015;60(1):110\u20132.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"906_CR75","first-page":"CD012798","volume":"8","author":"J Green","year":"2018","unstructured":"Green J, Carroll W, Gilchrist FJ. Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis. Cochrane Database Syst Rev. 2018;8(8):CD012798.","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"906_CR76","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","volume":"10","author":"C Colombo","year":"2011","unstructured":"Colombo C, Ellemunter H, Houwen R, Munck A, Taylor C, Wilschanski M, et al. Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J Cyst Fibros. 2011;10(Suppl 2):S24\u20138.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"906_CR77","first-page":"77","volume":"3","author":"CJ Taylor","year":"2002","unstructured":"Taylor CJ, Aswani N. The pancreas in cystic fibrosis. Paediatr Respir Rev. 2002;3(1):77\u201381.","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"906_CR78","doi-asserted-by":"publisher","first-page":"G868","DOI":"10.1152\/ajpgi.00261.2017","volume":"315","author":"DR McHugh","year":"2018","unstructured":"McHugh DR, Cotton CU, Moss FJ, Vitko M, Valerio DM, Kelley TJ, et al. Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium\/hydrogen exchanger 3. Am J Physiol Gastrointest Liver Physiol. 2018;315(5):G868\u201378.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"906_CR79","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1345\/aph.1Q219","volume":"45","author":"CE O'Brien","year":"2011","unstructured":"O\u2019Brien CE, Anderson PJ, Stowe CD. Lubiprostone for constipation in adults with cystic fibrosis: a pilot study. Ann Pharmacother. 2011;45(9):1061\u20136.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"906_CR80","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.cgh.2021.04.005","volume":"20","author":"MA Benninga","year":"2022","unstructured":"Benninga MA, Hussain SZ, Sood MR, Nurko S, Hyman P, Clifford RA, et al. Lubiprostone for pediatric functional constipation: randomized, controlled, double-blind study with long-term extension. Clin Gastroenterol Hepatol. 2022;20(3):602-10 e5.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"906_CR81","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40261-017-0614-0","volume":"38","author":"DP Rosenbaum","year":"2018","unstructured":"Rosenbaum DP, Yan A, Jacobs JW. Pharmacodynamics, safety, and tolerability of the NHE3 inhibitor tenapanor: two trials in healthy volunteers. Clin Drug Investig. 2018;38(4):341\u201351.","journal-title":"Clin Drug Investig"},{"issue":"7","key":"906_CR82","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1053\/j.gastro.2023.02.013","volume":"164","author":"SSC Rao","year":"2023","unstructured":"Rao SSC, Quigley EMM, Chey WD, Sharma A, Lembo AJ. Randomized Placebo-controlled phase 3 trial of vibrating capsule for chronic constipation. Gastroenterology. 2023;164(7):1202-10 e6.","journal-title":"Gastroenterology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-023-00906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-023-00906-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-023-00906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T14:11:17Z","timestamp":1706019077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-023-00906-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s11894-023-00906-4","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"26 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No animals or humans participated in this review paper. The one patient whose manometry was used consented to participation in this data but as no identifiers are used, our IRB at Atrium Health does not require informed consent as this is exempt from requiring IRB consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This review does not contain any studies of human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Dhiren Patel: None.Folashade Jose: None.Jason Baker: Anx Robotics.Baha Moshiree: Ardelyx: Speaker and Advisory Board, Medtronic- Research grant support, Takeda: Advisory board, Ironwood Pharmaceuticals: Advisory board and speaker, Abbvie- Advisory board, Bausch\/Salix pharmaceuticals: Speaker and Grant Support, Nestle Foundation: Speaker, Restalsis: Research Grant support, Coloplast: research grant support, Atmo- Research grant support, advisory board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}